Sylogist Ltd. (TSE:SYZ – Get Free Report) Director Andrew Anthony Shen bought 689,175 shares of the company’s stock in a transaction on Thursday, June 18th. The shares were bought at an average price of C$3.70 per share, for a total transaction of C$2,549,947.50. Following the transaction, the director owned 916,875 shares of the company’s stock, valued at approximately C$3,392,437.50. This represents a 302.67% increase in their ownership of the stock.
Andrew Anthony Shen also recently made the following trade(s):
- On Wednesday, June 17th, Andrew Anthony Shen purchased 100 shares of Sylogist stock. The stock was bought at an average cost of C$3.70 per share, with a total value of C$370.00.
- On Monday, June 15th, Andrew Anthony Shen purchased 3,500 shares of Sylogist stock. The stock was bought at an average price of C$3.66 per share, with a total value of C$12,810.00.
Sylogist Price Performance
Shares of TSE SYZ opened at C$3.75 on Friday. The company has a debt-to-equity ratio of 70.73, a quick ratio of 0.51 and a current ratio of 0.76. Sylogist Ltd. has a fifty-two week low of C$3.03 and a fifty-two week high of C$9.89. The stock has a market cap of C$87.36 million, a PE ratio of -11.72 and a beta of 0.39. The stock has a fifty day moving average of C$3.66 and a 200-day moving average of C$4.27.
Wall Street Analyst Weigh In
Separately, Ventum Financial cut shares of Sylogist from a “buy” rating to a “hold” rating and reduced their price objective for the company from C$7.00 to C$4.75 in a research note on Friday, March 20th. Two analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of C$4.75.
Read Our Latest Research Report on Sylogist
Sylogist Company Profile
Sylogist provides mission-critical SaaS solutions to over 2,000 public sector customers across the government, nonprofit, and education market segments. The Company’s stock is traded on the Toronto Stock Exchange under the symbol SYZ. Information about Sylogist, inclusive of full financial statements together with Management’s Discussion and Analysis, can be found at sedarplus.ca or at sylogist.com.
Further Reading
- Five stocks we like better than Sylogist
- Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself?
- Rackspace’s AI Land Grab: Plugging Into the Next Compute Boom
- Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore
- Why Kroger’s Pullback Could Be a Gift for Patient Investors
Receive News & Ratings for Sylogist Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sylogist and related companies with MarketBeat.com's FREE daily email newsletter.
